10.99 Gain Turns Cumberland Pharmaceuticals Inc (CPIX) Into A Winning Stock For Investors

Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) has a beta value of 0.01 and has seen 0.18 million shares traded in the last trading session. The company, currently valued at $72.31M, closed the last trade at $5.15 per share which meant it gained $0.51 on the day or 10.99% during that session. The CPIX stock price is -24.85% off its 52-week high price of $6.43 and 79.81% above the 52-week low of $1.04. If we look at the company’s 10-day average daily trading volume, we find that it stood at 8.36 million shares traded. The 3-month trading volume is 3.37 million shares.

Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) trade information

Sporting 10.99% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CPIX stock price touched $5.15 or saw a rise of 2.65%. Year-to-date, Cumberland Pharmaceuticals Inc shares have moved 117.30%, while the 5-day performance has seen it change 15.21%. Over the past 30 days, the shares of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) have changed 87.96%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.45.

Cumberland Pharmaceuticals Inc (CPIX) estimates and forecasts

The company’s shares have gained 270.50% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 0.31% over the past 5 years.

CPIX Dividends

Cumberland Pharmaceuticals Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)’s Major holders

Insiders own 44.15% of the company shares, while shares held by institutions stand at 22.01% with a share float percentage of 39.41%. Investors are also buoyed by the number of investors in a company, with Cumberland Pharmaceuticals Inc having a total of 24.0 institutions that hold shares in the company. The top two institutional holders are RENAISSANCE TECHNOLOGIES LLC with over 0.54 million shares worth more than $0.82 million. As of 2024-06-30, RENAISSANCE TECHNOLOGIES LLC held 3.8173% of shares outstanding.

The other major institutional holder is VANGUARD GROUP INC, with the holding of over 0.37 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.57 million and represent 2.6546% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Fund. As of Sep 30, 2024 , the former fund manager holds about 2.00% shares in the company for having 280.82 shares of worth $1.45 million while later fund manager owns 233.07 shares of worth $1.2 million as of Sep 30, 2024 , which makes it owner of about 1.66% of company’s outstanding stock.